Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLSN

Imunon (CLSN) Stock Price, News & Analysis

Imunon logo

About Imunon Stock (NASDAQ:CLSN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.95
$2.63
52-Week Range
N/A
Volume
711 shs
Average Volume
150,471 shs
Market Capitalization
$13.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imunon and its competitors with MarketBeat's FREE daily newsletter.

CLSN Stock News Headlines

Imunon Inc IMNN
CLSN.L Regulatory News
140% Yields From Stocks Like Tesla? Here's How (July 4th Special)
Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, Apple, and Amazon. And for the July 4th holiday...I'm sharing this secret for just $9.
See More Headlines

CLSN Stock Analysis - Frequently Asked Questions

Imunon, Inc. (NASDAQ:CLSN) announced its quarterly earnings results on Monday, August, 15th. The biotechnology company reported ($0.87) earnings per share for the quarter, beating the consensus estimate of ($1.12) by $0.25. Imunon had a negative net margin of 5,229.80% and a negative trailing twelve-month return on equity of 50.18%.

Shares of Imunon reverse split on Tuesday, March 1st 2022.The 1-15 reverse split was announced on Tuesday, March 1st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, March 1st 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imunon investors own include Tonix Pharmaceuticals (TNXP), Tesla (TSLA), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Acasti Pharma (ACST), Corbus Pharmaceuticals (CRBP) and Dynavax Technologies (DVAX).

Company Calendar

Last Earnings
8/15/2022
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CLSN
Employees
27
Year Founded
1982

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.77 million
Net Margins
-5,229.80%
Pretax Margin
-5,506.60%

Debt

Sales & Book Value

Annual Sales
$500 thousand
Price / Cash Flow
N/A
Book Value
$9.66 per share
Price / Book
N/A

Miscellaneous

Free Float
6,768,000
Market Cap
$13.91 million
Optionable
Optionable
Beta
2.27

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:CLSN) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners